POSEIDON BIO, LLC enters OCEAN BIOMEDICAL HOLDINGS, INC. with 22.84M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/16/2023ACC: 0001493152-23-005362
10% Owner
Since Feb 2023
22.84M
Baseline shares
100% direct
22.84M
Direct ownership
1 position
18.58M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Class A Common Stock, par value $0.0001
DirectShares owned22.84M
Total
22.84M direct22.84M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock, par value $0.0001 | 22.84M | Direct |
| Total | 22.84M | 22.84M direct |
Derivative Holdings1
Earnout Rights
DirectUnderlying security
Class A Common Stock
Underlying shares
18.58M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
18.58M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Earnout Rights Direct | Class A Common Stock | — | — | 18.58M | N/A | |
| Total | 18.58M | 0.00 | ||||